Skip to content

Effect of Dexmedtomidine on postoperative pain in third molar surgery

The effect of Dexmedtomidine plus Bupivacaine on postoperative pain in mandibular third molar Surgery.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190819044566N1
Enrollment
60
Registered
2019-09-18
Start date
2019-10-22
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post dental surgery pain. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: subjects receive a mixture of Bupivacaine 0.5% (1.8 ml) with epinephrine 1:200000 (Novocal Pharmucautical of Canada Inc. Cambridye, Ontario N1R6) and 0.5 mg/kg Dexm

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Patients with impacted wisdom tooth (Mesioangular, class II B in Pel and Gregory classification) 18 to 30 years old ASA I status Referred to Shahid Beheshti Dental School for Surgery and willing to be enrolled in the study

Exclusion criteria

Exclusion criteria: Patients who receive psychological drugs or have drug addiction More than one tooth surgery or other dental treatments such as root canal therapy Impact tooth in other categories of Pel and Gregory classification Refuse to study enrollment Women in menses

Design outcomes

Primary

MeasureTime frame
Post surgical pain. Timepoint: 4, 8, 12 hours after surgery. Method of measurement: The pain severity is measured using visual analogue scale by asking patients: 0-10 (0-3 mild, 4-6 moderate and 7-10 sever which subjects need pain relief drugs).;The amount of analgesics that is used by patients. Timepoint: Consumption of analgesic within 12 hours after surgery. Method of measurement: Asking patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPegah Mehrabi Nia

Shahid Beheshti University of Medical Sciences

pegahmehrabinia@yahoo.com+98 920 510 6983

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026